1001-5256
2015 Issue 7
..............page:986
Research advances in non- alcoholic fatty liver disease: a review of current status and prospect
FAN Jiangao;Center for Fatty Liver;Department of Gastroenterology;Xinhua Hospital;Shanghai Jiao Tong University School of Medicine;
FAN Jiangao;Center for Fatty Liver;Department of Gastroenterology;Xinhua Hospital;Shanghai Jiao Tong University School of Medicine;
..............page:999-1001
Expert consensus on treatment methods for spleen injury( 2014)
Group of Splenic Function and Spleen Surgery;Chinese Society of Surgery;Chinese Medical Association;
Group of Splenic Function and Spleen Surgery;Chinese Society of Surgery;Chinese Medical Association;
..............page:1002-1003
Interpretation of 2015 WHO guidelines for the prevention,care and treatment of persons with chronic hepatitis B infection: comparison antiviral treatment of chronic hepatitis B
DAI Mingjia;LENG Xuejun;YAN Xuebing;Department of Infectious Diseases;The Affiliated Hospital of Xuzhou Medical College;
DAI Mingjia;LENG Xuejun;YAN Xuebing;Department of Infectious Diseases;The Affiliated Hospital of Xuzhou Medical College;
..............page:1004-1007
EASL recommendations on treatment of hepatitis C 2015
RAO Huiying;WEI Lai;Peking University People’s Hospital;Peking University Hepatology Institute;
RAO Huiying;WEI Lai;Peking University People’s Hospital;Peking University Hepatology Institute;
..............page:1008-1017
Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites
WANG Shuai;HU Darong;Institute of Hepatology;General Hospital of Beijing Military Command;
WANG Shuai;HU Darong;Institute of Hepatology;General Hospital of Beijing Military Command;
..............page:1018-1022
tu san qi dao zhi gan zuo zu sai zong he zheng - xi tong ping jia zhong guo wen xian
wang xiao xi ; qi xing shun ; guo xiao zhong ;
wang xiao xi ; qi xing shun ; guo xiao zhong ;
..............page:1022
2015 Standards of Practice Committee of the American Society for Gaserointestinal Endoscopy guideline: the role of ERCP in benign diseases of the biliary tract
CHEN Gang;LIU Hong;LI Li;Department of Hepatobiliary surgery;Ganmei Hospital Affiliated to Kunming Medical University;
CHEN Gang;LIU Hong;LI Li;Department of Hepatobiliary surgery;Ganmei Hospital Affiliated to Kunming Medical University;
..............page:1023-1026
..............page:1026
2015 The Japanese Society of Gastroenterology of Evidence- based clinical practice guidelines for nonalcoholic fatty liver disease / nonalcoholic steatohepatitis
CHANG Binxia;ZOU Zhengsheng;LI Baosen;Center for Non - Infectious Liver Diseases;302 Hospital of PLA;
CHANG Binxia;ZOU Zhengsheng;LI Baosen;Center for Non - Infectious Liver Diseases;302 Hospital of PLA;
..............page:1027-1030
..............page:1030
2014 Korean Liver Cancer Study Group- National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma: an excerpt of recommendations
ZHAO Jiancheng;QI Xingshun;GUO Xiaozhong;Department of Gastroenterology;General Hospital of Shenyang Military Area Command;
ZHAO Jiancheng;QI Xingshun;GUO Xiaozhong;Department of Gastroenterology;General Hospital of Shenyang Military Area Command;
..............page:1031-1033
..............page:1033
Hepatitis C virus related fatty liver
ZHANG Yu;CHENG Jun;Institute of Infectious Diseases;Beijing Ditan Hospital;Capital Medical University;
ZHANG Yu;CHENG Jun;Institute of Infectious Diseases;Beijing Ditan Hospital;Capital Medical University;
..............page:1034-1037
Application of lipid- regulating drugs in non- alcoholic fatty liver disease
CUI Ruibing;YAN Ming;Qilu Hospital of Shandong University;
CUI Ruibing;YAN Ming;Qilu Hospital of Shandong University;
..............page:1038-1041
Role of gut microbiota regulation in traditional Chinese medicine treatment of non- alcoholic fatty liver disease
TIAN Huajie;FENG Qin;HU Yiyang;Shuguang Hospital & Institute of Hepatology;Shanghai University of Traditional Chinese Medicine;
TIAN Huajie;FENG Qin;HU Yiyang;Shuguang Hospital & Institute of Hepatology;Shanghai University of Traditional Chinese Medicine;
..............page:1042-1045
xue qing duo hua zi teng ning ji su yang xing ju shi xi bao jie he dan bai shui ping ying xiang gan ying hua huan zhe gan zang chu bei gong neng he bing si lv
wang shan ; wen xiao yu ;
wang shan ; wen xiao yu ;
..............page:1045
Research advances in association between non- alcoholic fatty liver disease and cardiovascular disease
LI Qiang;ZHUO Qibin;CHEN Liang;First Department of Hepatitis;Shanghai Public Health Clinical Center Affiliated to Fudan University;
LI Qiang;ZHUO Qibin;CHEN Liang;First Department of Hepatitis;Shanghai Public Health Clinical Center Affiliated to Fudan University;
..............page:1046-1049
Roles of abnormal lipid metabolism in pathogenesis of non- alcoholic fatty liver disease
LU Ran;HONG Tianpei;Department of Endocrinology;Peking University Third Hospital;
LU Ran;HONG Tianpei;Department of Endocrinology;Peking University Third Hospital;
..............page:1050-1054
ti bi fu ding en ti ka wei ti nuo fu wei zhi liao man xing yi xing gan yan huan zhe de shen zang an quan xing ji you xiao xing de dui bi
cheng shi jia ; wang chong ;
cheng shi jia ; wang chong ;
..............page:1054
Research advances in genetic susceptibility to non- alcoholic fatty liver disease
YUAN Chen;CHENG Yuting;JIANG Man;Second Department of Gastroenterology;Qingdao Municipal Hospital;
YUAN Chen;CHENG Yuting;JIANG Man;Second Department of Gastroenterology;Qingdao Municipal Hospital;
..............page:1055-1058
Analysis of correlation between serum 25- hydroxyvitamin D level and nonalcoholic fatty liver disease
CAI Wen;DONG Zhenghui;WANG Shuxia;School of Nursing;Xinjiang Medical University;
CAI Wen;DONG Zhenghui;WANG Shuxia;School of Nursing;Xinjiang Medical University;
..............page:1059-1062
Prevalence and clinical features of hepatic steatosis in patients with chronic hepatitis B
ZHANG Zhiqiao;WANG Gongsui;KANG Kaifu;Department of Infectious Diseases;The First People’ s Hospital of Shunde;
ZHANG Zhiqiao;WANG Gongsui;KANG Kaifu;Department of Infectious Diseases;The First People’ s Hospital of Shunde;
..............page:1063-1067
Clinical efficacy of Liuweiwuling tablets in treatment of non- alcoholic fatty liver disease: a meta- analysis
ZHOU Lijun;Department of Internal Medicine of Traditional Chinese Medicine;The First People’ s Hospital of Wuxue;
ZHOU Lijun;Department of Internal Medicine of Traditional Chinese Medicine;The First People’ s Hospital of Wuxue;
..............page:1068-1072
xue qing duo hua zi teng ning ji su yang xing ju shi xi bao jie he dan bai shui ping ke yi yu ce gan xian wei hua he yuan fa xing dan zhi xing gan ying hua de yu hou
xu hong qin ; li wan yu ;
xu hong qin ; li wan yu ;
..............page:1072
Fatty liver and light manual labor: an epidemiological survey in Tianjin by controlled attenuation parameter
LI Hai;LIU Chuncheng;WANG Yulin;Second Department of Gastroenterology;The Affiliated Hospital of Logistics University of Chinese People’s Armed Police Forces;
LI Hai;LIU Chuncheng;WANG Yulin;Second Department of Gastroenterology;The Affiliated Hospital of Logistics University of Chinese People’s Armed Police Forces;
..............page:1073-1077
..............page:1077
Changes in intestinal flora in nonalcoholic fatty liver disease: their correlation with insulin resistance index,tumor necrosis factor- α,and interleukin- 6
ZHANG Qiunan;XIAO Ying;MIAO Ruixin;Department of Gastroenterology;Central Hospital of Huludao;
ZHANG Qiunan;XIAO Ying;MIAO Ruixin;Department of Gastroenterology;Central Hospital of Huludao;
..............page:1078-1081
gan rao su you dao de 25- dan gu chun zuo hua mei tong guo zu duan mo xing wang luo de xing cheng xian zhi hcv fu zhi
qi yue ; wang zhong feng ;
qi yue ; wang zhong feng ;
..............page:1081
Association between AGTR1 gene polymorphism and risk of nonalcoholic fatty liver disease
LIU Yang;JIANG Man;CHEN Lizhen;Second Department of Gastroenterology;Qingdao Municipal Hospital;Qingdao University Medical College;
LIU Yang;JIANG Man;CHEN Lizhen;Second Department of Gastroenterology;Qingdao Municipal Hospital;Qingdao University Medical College;
..............page:1082-1087
..............page:1087
Association between PPARγ gene rs3856806 polymorphism and nonalcoholic fatty liver disease
XU Xin;JIANG Man;LI Jiangwen;Dalian Medical University;
XU Xin;JIANG Man;LI Jiangwen;Dalian Medical University;
..............page:1088-1091
..............page:1091
Association between GCKR gene rs780094( C > T) polymorphism and non- alcoholic fatty liver disease in Han population in Qingdao,China
DONG Quanyong;XU Xin;LI Jiangwen;Dalian Medical University;
DONG Quanyong;XU Xin;LI Jiangwen;Dalian Medical University;
..............page:1092-1095
Risk factors for complications after laparoscopic cholecystectomy in elderly patients aged over 60
WANG Jun;Department of General Surgery;Beijing Changping Hospital of Traditional Chinese Medicine;
WANG Jun;Department of General Surgery;Beijing Changping Hospital of Traditional Chinese Medicine;
..............page:1096-1098
Expression of Grb2,MMP- 3,and MMP- 9 in cholangiocarcinoma and its significance
ZHAO Tingkuan;LI Chunyan;YANG Yong;Department of Pathology;Jingzhou Central Hospital;
ZHAO Tingkuan;LI Chunyan;YANG Yong;Department of Pathology;Jingzhou Central Hospital;
..............page:1099-1102
shen sun shang dui gan yi zhi hou fei jiu jing xing zhi fang xing gan yan gan ying hua huan zhe xin xue guan ji bing bing si lv fang mian de ying xiang
lu wang ; li wan yu ;
lu wang ; li wan yu ;
..............page:1102
Dietary intake of selenium and serum selenium in patients with chronic hepatitis B,liver cirrhosis and acute- on-chronic liver failure
ZHAO Juan;LI Juan;YU Hongwei;Department of Critical Care Medicine of Liver Disease;Beijing Youan Hospital;Capital Medical University;
ZHAO Juan;LI Juan;YU Hongwei;Department of Critical Care Medicine of Liver Disease;Beijing Youan Hospital;Capital Medical University;
..............page:1103-1106
..............page:1106
Comparison of efficacy between sodium morrhuate and lauromacrogol as sclerosing agents in treatment of hepatic cyst
QIN Zuyun;GUO Yabing;Department of Liver Disease;Guidong People’s Hospital;
QIN Zuyun;GUO Yabing;Department of Liver Disease;Guidong People’s Hospital;
..............page:1107-1109
shang pi xi bao zhuan hua xu lie 2 diao kong rho/erk xin hao zhuan dao tong lu cu shi gan ai zao qi fu fa
cao wen li ; wen xiao yu ;
cao wen li ; wen xiao yu ;
..............page:1109
Correlation between liver damage degree and clinical manifestations in patients with pulmonary tuberculosis after chemotherapy
SUN Ying;LI Runpu;WANG Xiaojie;Department of Infectious Diseases;The Second Central Hospital of Baoding;
SUN Ying;LI Runpu;WANG Xiaojie;Department of Infectious Diseases;The Second Central Hospital of Baoding;
..............page:1110-1113
..............page:1113
Ganshuang granules protect mouse liver from chronic injury induced by CCl4 via autophagy
SUN Haiqing;WANG Xiaoqi;SHI Hongbo;Beijing Youan Hospital;Capital University of Medical Sciences;
SUN Haiqing;WANG Xiaoqi;SHI Hongbo;Beijing Youan Hospital;Capital University of Medical Sciences;
..............page:1114-1119
..............page:1119
Clinical characteristics of multiple ERCP procedures in elderly patients aged over 80
WANG Jiheng;SU Ximing;GAO Ge;Department of Gastroenterology;Beijing Army General Hospital;
WANG Jiheng;SU Ximing;GAO Ge;Department of Gastroenterology;Beijing Army General Hospital;
..............page:1120-1122
Analysis of high- risk groups and predictive factors for hepatic steatosis in patients with chronic hepatitis B
ZHANG Zhiqiao;WANG Gongsui;KANG Kaifu;Department of Infectious Diseases;The First People’ s Hospital of Shunde;
ZHANG Zhiqiao;WANG Gongsui;KANG Kaifu;Department of Infectious Diseases;The First People’ s Hospital of Shunde;
..............page:1123-1125
Hepatitis E- associated pure red cell aplasia: a report of one case
HAO Kunyan;YU Yuecheng;GAO Lei;Liver Diseases Center of PLA;81 Hospital of PLA;
HAO Kunyan;YU Yuecheng;GAO Lei;Liver Diseases Center of PLA;81 Hospital of PLA;
..............page:1126-1127
Severe liver damages induced by Huolisu oral liquid taken with euthyrox: a report of two cases
ZHAO Jianxue;LU Weiting;LIU Mantian;Department of Infectious Diseases;Jiangsu Provincial Hospital of Traditional Chinese Medicine;
ZHAO Jianxue;LU Weiting;LIU Mantian;Department of Infectious Diseases;Jiangsu Provincial Hospital of Traditional Chinese Medicine;
..............page:1128-1129
One case of acute liver damage induced by Yasmin
KONG Wenli;YANG Yiliang;PENG Shanshan;Department of Hepatology;The First Hospital of Jilin University;
KONG Wenli;YANG Yiliang;PENG Shanshan;Department of Hepatology;The First Hospital of Jilin University;
..............page:1130-1131
kang bing du zhi liao dui yu yi xing gan yan gan ying hua shi dai chang qi huan zhe bing cheng de chang qi ying xiang
peng zuo zuo ; wang chong ;
peng zuo zuo ; wang chong ;
..............page:1131
Hepatic veno- occlusive disease induced by Gynura segetum: a report of two cases
PENG Shanshan;CUI Yuanyuan;KONG Wengli;Department of Hepatology;The First Hospital of Jilin University;
PENG Shanshan;CUI Yuanyuan;KONG Wengli;Department of Hepatology;The First Hospital of Jilin University;
..............page:1132-1134
..............page:1134
Research advances in treatment of non- alcoholic fatty liver disease
LI Qiang;ZHUO Qibin;CHEN Liang;First Department of Hepatitis;Shanghai Public Health Clinical Center Affiliated to Fudan University;
LI Qiang;ZHUO Qibin;CHEN Liang;First Department of Hepatitis;Shanghai Public Health Clinical Center Affiliated to Fudan University;
..............page:1135-1139
Research advances in fatty donor liver in liver transplantation
CAO Haiyang;WU Xiaofeng;LIN Dongdong;Department of Anesthesia;Beijing Youan Hospital;Capital Medical University;
CAO Haiyang;WU Xiaofeng;LIN Dongdong;Department of Anesthesia;Beijing Youan Hospital;Capital Medical University;
..............page:1140-1143
..............page:1143
Research advances in adiponectin actions in nonalcoholic fatty liver disease
FEI Xinying;SHEN Zhen;WANG Jiangang;Huangshi Hospital of Traditional Chinese Medicine;
FEI Xinying;SHEN Zhen;WANG Jiangang;Huangshi Hospital of Traditional Chinese Medicine;
..............page:1144-1146
Research advances in innate immunity mechanism of nonalcoholic fatty liver disease
ZHAI Qingqing;ZHOU Zhenhua;WANG Weijian;Department of Hepatopathy;Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine;
ZHAI Qingqing;ZHOU Zhenhua;WANG Weijian;Department of Hepatopathy;Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine;
..............page:1147-1152
Role of Toll- like receptors in development and progression of nonalcoholic fatty liver disease
CHEN Jie;ZHANG Jing;HE Qiushui;Department of Toxic Hepatopathy;Beijing Youan Hospital Affiliated to Capital Medical University;
CHEN Jie;ZHANG Jing;HE Qiushui;Department of Toxic Hepatopathy;Beijing Youan Hospital Affiliated to Capital Medical University;
..............page:1153-1155
Research progress in role of myosin light chain kinase in pathogenesis of nonalcoholic fatty liver disease
LI Chunmiao;ZHUANG Liwei;The Fourth Hospital of Harbin Medical University;
LI Chunmiao;ZHUANG Liwei;The Fourth Hospital of Harbin Medical University;
..............page:1156-1159
ren hbsag hbeag yi zhi gan rao su you dao tong lu zuo long ti zhu dan bai xin hao
yang kun ; li wan yu ;
yang kun ; li wan yu ;
..............page:1159
Role of Ghrelin in development and progression of nonalcoholic fatty liver disease
XU Jia;MA Jingting;LI Dongfu;Department of Hepatobiliary and Pancreatic Diseases;The Second Hospital of Jilin University;
XU Jia;MA Jingting;LI Dongfu;Department of Hepatobiliary and Pancreatic Diseases;The Second Hospital of Jilin University;
..............page:1160-1162
Gene polymorphisms in non- alcoholic fatty liver disease: a review of research progress
ZHU Duanquan;WU Hao;GONG Jianping;Department of General Surgery;The First People’s Hospital of Wanzhou;
ZHU Duanquan;WU Hao;GONG Jianping;Department of General Surgery;The First People’s Hospital of Wanzhou;
..............page:1163-1167
Research advances in cell models of hepatitis B virus
WU Jiang;ZHOU Zhenhua;SUN Xuehua;Department of Hepatopathy;Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine;
WU Jiang;ZHOU Zhenhua;SUN Xuehua;Department of Hepatopathy;Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine;
..............page:1168-1172
xue qing sheng chang fen hua yin zi 15 shui ping dui gan ying hua he gan xi bao ai zhen duan de yi yi
meng jing ; wang zhong feng ;
meng jing ; wang zhong feng ;
..............page:1172
Risk factors for portal vein thrombosis following splenectomy in patients with liver cirrhosis
YANG Zhengmao;ZHANG Lingyi;Department of Infectious Disease;The Second People’s Hospital of Lanzhou City;
YANG Zhengmao;ZHANG Lingyi;Department of Infectious Disease;The Second People’s Hospital of Lanzhou City;
..............page:1173-1175
Application of tumor necrosis factor antagonists in hepatic disease treatment
CHI Zhaochun;GENG Changxin;Department of Gastroenterology;Qingdao Municipal Hospital;Affiliated Hospital of College of Pharmacy;Ocean University of China;
CHI Zhaochun;GENG Changxin;Department of Gastroenterology;Qingdao Municipal Hospital;Affiliated Hospital of College of Pharmacy;Ocean University of China;
..............page:1176-1179